경피 피부 패치 시장 : 유형별, 용도별, 유통 채널별, 지역별
Transdermal Skin Patches Market, By Type, By Application, By Distribution Channel, By Geography
상품코드
:
1672906
리서치사
:
Coherent Market Insights
발행일
:
2025년 02월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
경피 피부 패치 세계 시장은 2025년에 92억 9,000만 달러, 2032년에는 137억 1,000만 달러에 달할 것으로 예측되며, 2025-2032년 연평균 5.7%의 성장률을 나타낼 것으로 예상됩니다.
| 보고 범위 |
보고서 상세 내용 |
| 기준 연도 |
2024년 |
2025년 시장 규모 |
92억 9,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간(2025-2032년) CAGR |
5.70% |
2032년 금액 예측 |
137억 1,000만 달러 |
그림. 경피 피부 패치 시장 점유율(%), 2025년 지역별 시장 점유율
경피 피부 패치 세계 시장은 다양한 만성 질환의 세계 유병률 증가로 인해 지난 몇 년동안 견인력을 얻고 있습니다. 경피용 패치는 편리한 약물 전달 모드를 제공하며, 기존의 약물 전달 방법에 비해 몇 가지 장점을 가지고 있습니다. 이 패치는 약물을 피부에서 혈류로 미리 정해진 속도로 정해진 기간 동안 투여합니다. 경구 투여로 인한 위장 자극을 최소화하고 장기간에 걸쳐 약물을 방출할 수 있습니다. 또한, 경피 피부 패치는 비침습적이고 통증이 없는 약물 전달을 제공하여 환자의 치료 순응도를 향상시킵니다. 노인 인구 증가, 약물 자가 투여에 대한 수요 증가, 편리한 약물 전달 시스템에 대한 수요 증가는 향후 몇 년동안 경피용 패치 수요를 촉진할 것으로 예상되는 주요 요인 중 일부입니다.
시장 역학
심혈관 질환, 당뇨병, 만성 통증, 암, 신경 장애와 같은 만성 질환의 유병률 증가는 경피적 피부 패치의 세계 채택을 촉진하는 주요 요인입니다. 또한, 만성질환에 취약한 노인 인구 증가도 시장 개척을 촉진하고 있습니다. 편의성과 사용 편의성 때문에 비침습적, 비침습적 약물 전달 시스템에 대한 환자 및 간병인의 선호도가 높아지면서 경피용 패치 수요를 더욱 증가시키고 있습니다. 반면, 경피 피부 패치 기반 약물 전달 시스템과 관련된 높은 개발 비용과 임상시험과 관련된 규제 이슈는 예측 기간 동안 시장 성장을 어느 정도 억제할 것으로 예상되는 요인 중 일부입니다. 그러나 제형 기술의 발전으로 인해 보다 광범위한 약물 전달 속도가 향상되고 있습니다. 이는 시장 진출기업들에게 유리한 성장 기회를 제공할 것으로 예상됩니다.
본 조사의 주요 특징
- 세계의 경피 피부 패치 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 동안 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등 다양한 매개 변수를 기반으로 세계 경피 피부 패치 시장의 주요 업체를 프로파일링합니다.
- 주요 기업으로는 Novartis AG, Purdue Pharma L.P., Viatris, Inc. LUYE PHARMA AG,Samyang Holdings Corporation,Vektor Pharma,Hisamitsu Pharmaceutical Co. Inc.,Nitto Denko Corporation,Gedeon Richter Plc.,Agile Therapeutics,Amneal Pharmaceuticals LLC.,Cipla,AdhexPharma 등이 있습니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 경피 피부 패치 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 경피 피부 패치 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map (COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 시장 동향
- 규제 시나리오
- 제조업체 매출
- 인수와 제휴 시나리오
- 제품 발매/승인
- 자금조달과 투자
- PEST 분석
- Porter의 Five Forces 분석
제4장 세계의 경피 피부 패치 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- 정부 이니셔티브
- 시장에 대한 COVID-19의 영향
제5장 세계의 경피 피부 패치 시장, 유형별, 2020-2032년(10억 달러)
- 서론
- 단층 약제 함유 접착제
- 다층 약제 내접착제
- 매트릭스
- 기타
제6장 세계의 경피 피부 패치 시장, 용도별, 2020-2032년(10억 달러)
- 서론
- 통증 완화
- 금연
- 과민성 방광
- 호르몬 요법
- 기타
제7장 세계의 경피 피부 패치 시장, 유통 채널별, 2020-2032년(10억 달러)
제8장 세계의 경피 피부 패치 시장, 지역별, 2020-2032년(10억 달러)
- 서론
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제9장 경쟁 구도
- 기업 개요
- Novartis AG
- Purdue Pharma LP
- Viatris, Inc.
- Teikoku Pharma USA, Inc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- LUYE PHARMA AG
- Samyang Holdings Corporation
- Vektor Pharma
- Hisamitsu Pharmaceutical Co., Inc.
- UCB SA
- Hikma Pharmaceuticals PLC
- Corium, Inc.
- Nitto Denko Corporation
- Gedeon Richter Plc.
- Agile Therapeutics
- Amneal Pharmaceuticals LLC.
- Cipla
- AdhexPharma
제10장 애널리스트의 견해
- 융성과 쇠퇴
- Coherent Opportunity Map
제11장 참고 문헌과 조사 방법
LSH
영문 목차
Global Transdermal Skin Patches Market is estimated to be valued at USD 9.29 Bn in 2025 and is expected to reach USD 13.71 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 9.29 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
5.70% |
2032 Value Projection: |
USD 13.71 Bn |
Figure. Transdermal Skin Patches Market Share (%), By Region 2025
The global transdermal skin patches market has been gaining traction over the past few years owing to the growing prevalence of various chronic diseases globally. Transdermal skin patches provide a convenient mode of delivery of drugs and offer several advantages over conventional drug delivery methods. These patches administer medication through the skin and into the bloodstream at a predetermined rate for an intended duration. They minimize gastric irritation caused by oral administration of drugs and provide controlled release of drug for an extended period of time. Moreover, transdermal skin patches offer non-invasive and painless delivery of drugs, which enhances patient compliance in therapy. Rising geriatric population, increasing demand for self-administration of drugs, and growing need for convenient drug delivery systems are some of the key factors anticipated to fuel the demand for transdermal skin patches in the coming years.
Market Dynamics:
Growing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, chronic pain, cancer, and neurological disorders, is a key factor boosting the adoption of transdermal skin patches globally. Moreover, the rising geriatric population who are more prone to develop chronic conditions is also augmenting the market growth. The growing preference of patients and care-givers for non-invasive and needle-free drug delivery systems owing to convenience and ease-of-use is further propelling the demand for transdermal skin patches. On the other hand, high development costs associated with transdermal patch-based drug delivery systems and regulatory challenges pertaining to clinical trials are some of the factors expected to restrain the market growth to a certain extent over the forecast period. However, ongoing advancements in formulation technologies are aimed at enhancing delivery rates of a wider range of drugs. This is expected to offer lucrative growth opportunities for players in this market.
Key Features of the Study:
- This report provides an in-depth analysis of the global transdermal skin patches market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global transdermal skin patches market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this includes Novartis AG, Purdue Pharma L.P., Viatris, Inc., Teikoku Pharma USA, Inc., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., LUYE PHARMA AG, Samyang Holdings Corporation, Vektor Pharma, Hisamitsu Pharmaceutical Co.,Inc., UCB S.A., Hikma Pharmaceuticals PLC , Corium, Inc., Nitto Denko Corporation, Gedeon Richter Plc., Agile Therapeutics, Amneal Pharmaceuticals LLC., Cipla, and AdhexPharma
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global transdermal skin patches market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transdermal skin patches market.
Detailed Segmentation-
- By Type:
- Single-layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Matrix
- Others
- By Application:
- Pain Relief
- Smoking Cessation
- Overactive Bladder
- Hormonal Therapy
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Novartis AG
- Purdue Pharma L.P.
- Viatris, Inc.
- Teikoku Pharma USA, Inc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- LUYE PHARMA AG
- Samyang Holdings Corporation
- Vektor Pharma
- Hisamitsu Pharmaceutical Co., Inc.
- UCB S.A.
- Hikma Pharmaceuticals PLC
- Corium, Inc.
- Nitto Denko Corporation
- Gedeon Richter Plc.
- Agile Therapeutics
- Amneal Pharmaceuticals LLC.
- Cipla
- AdhexPharma
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Transdermal Skin Patches Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Transdermal Skin Patches Market, By Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Single-layer Drug-in-Adhesive
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Multi-layer Drug-in-Adhesive
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Matrix
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Transdermal Skin Patches Market, By Application, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Pain Relief
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Smoking Cessation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Overactive Bladder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hormonal Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Transdermal Skin Patches Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Transdermal Skin Patches Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Purdue Pharma L.P.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Viatris, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teikoku Pharma USA, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LUYE PHARMA AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Samyang Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vektor Pharma
- Hisamitsu Pharmaceutical Co., Inc.
- UCB S.A.
- Hikma Pharmaceuticals PLC
- Corium, Inc.
- Nitto Denko Corporation
- Gedeon Richter Plc.
- Agile Therapeutics
- Amneal Pharmaceuticals LLC.
- Cipla
- AdhexPharma
10. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
관련자료
